Insert the needle at a 90-degree angle perpendicular to skin, aim for subcutaneous tissue rather than muscle, and alternate between thighs, abdomen, and upper arms each week
Your provider will review your health history and medications before starting treatment
Separately, a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) by Godfrey et al., published in the Journal of the European Academy of Dermatology and Venereology (2025), found an elevated reporting odds ratio for alopecia with semaglutide of 2.46 (95% CI: 2.142.83)
All medications are compounded at licensed 503A pharmacies and shipped to your home in all 50 states
What GLP-1s do in your body: Stimulate insulin release from pancreatic beta cells Slow gastric emptying, which reduces appetite Get metabolized primarily by the liver Are cleared partially through kidney function Have unknown long-term effects on thyroid C-cells Nearly half of patients stop GLP-1 therapy within the first year